Monoclonal antibodies in the treatment of malignant lymphomas.
Coiffier
Bertrand
B
Hematology Department, Hospices Civils de Lyon and Claude Bernard University, Pierre-Benite, France. bertrand.coiffier@chu-lyon.fr
D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry* / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008223:Lymphoma / Q000628:therapy*; D008224:Lymphoma, Follicular / Q000628:therapy; D008495:Medical Oncology / Q000379:methods / Q000639:trends; D009362:Neoplasm Metastasis; D016032:Randomized Controlled Trials as Topic; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab